
DRUG vs EVO
$DRUG vs $EVO head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
DRUG vs EVO: the quick read
- ·EVO is the larger company by market cap ($544M vs $533M).
- ·DRUG has been more active on our scanner (26 vs 16 alerts in 30 days).
- ·DRUG has the smaller float (8.5M vs 342.4M), which tends to mean sharper, more volatile moves.
- ·Both are pharmaceutical preparations names, so this is a like-for-like comparison and sector news tends to move them together.
- ·They trade in different worlds by share price: EVO is a low-priced stock where a few cents is a real percentage move, while the other is priced for steadier increments.
- ·Both stay busy on our scanner, 26 and 16 unusual-volume alerts over 30 days, so neither is the quiet one here.
- ·They are closely matched in size, within 2% of each other on market cap, which makes the rest of this table the interesting part.
- ·Both sit in the bottom quarter of their 52-week range, so this is a comparison of two names well off their highs.
- ·EVO pays a dividend and DRUG does not, which usually means one is being held for income and the other for the move.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing DRUG and EVO on TheDesperateTrader.
- Is DRUG or EVO the better stock?
- "Better" depends on your goal, and these two are not alike. EVO is the larger company by market cap ($544M vs $533M). DRUG has been more active on our scanner (26 vs 16 alerts in 30 days). DRUG has the smaller float (8.5M vs 342.4M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between DRUG and EVO?
- The differences that matter: they are similar in size ($533M vs $544M); they trade at very different share prices ($54.28 vs $1.48); DRUG sits at 9% of its 52-week range against -1% for EVO; only EVO pays a dividend; our scanner flagged DRUG 26 times in the last 30 days against 16 for EVO. Everything above is measured from the latest completed session and SEC filings.
- Which of DRUG and EVO is more active right now?
- Right now DRUG is at about 0.8x its normal volume and EVO is at about 0.3x, so DRUG is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading DRUG or EVO? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysExplore the market
Free, live market tools. No account required to look.